Jonathan Berman has over 20 years of litigation experience, focusing on antitrust cases, class actions, and other complex litigation matters. He focuses on the interplay between civil litigation and the laws administered by the Food and Drug Administration. Jonathan also has advised clients, on dozens of matters, regarding FDA law and practice.
Jonathan's antitrust docket has included cases involving allegations of product-hopping, pay-for-delay, and price-fixing, government challenges to mergers, exclusive contracts, and a variety of rule-of-reason and monopolization theories. He frequently litigates on behalf of clients in the health care sector. Jonathan has represented, in major litigation, pharmaceutical companies, a drug wholesaler, an insurer, and hospitals.
Other litigation matters have included representing Prince Jefri Bolkiah, a member of the Royal Family of Brunei, in a series of complex litigations against the Brunei government, former advisors, and insurers. In addition, Jonathan argued one of the first litigated motions involving using predictive coding of electronic documents.
Jonathan's pro bono activities have included obtaining asylum for numerous immigrants fleeing political oppression. He has served on the Steering Committee of Operation Crackdown, an organization that has assisted neighborhood groups to abate drug nuisance properties in Washington, D.C.
Indivior defends against product hop allegations in antitrust class action
Dr. Reddy's Laboratories successfully defends against allegations of pay for delay in multidistrict antitrust class action litigation
Procter & Gamble defends against misbranding action
Honors & Distinctions
Vice Chair, American Bar Association, Subcommittee on Food, Cosmetics and Nutraceuticals (2015-2016)
Law Clerk to Judge R.R. McKelvie, U.S. District Court, District of Delaware (1993 term)